All data are based on the daily closing price as of July 10, 2025
h

Hyundai Bioscience

048410.KQ
7.89 USD
0.44
+5.91%

Overview

Last close
7.89 usd
Market cap
378.86M usd
52 week high
17.93 usd
52 week low
6.33 usd
Target price
N/A usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
47.5753
Price/Book Value
4.1877
Enterprise Value
318.17M usd
EV/Revenue
40.7452
EV/EBITDA
-64.6317

Key financials

Revenue TTM
7.81M usd
Gross Profit TTM
6.70M usd
EBITDA TTM
-2.87M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
96.62M usd
Net debt
N/A usd

About

Hyundai Bioscience Co., Ltd. operates as a biotechnology company. The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19. The company was founded in 2000 and is based in Seoul, South Korea.
  • Symbol
    048410.KQ
  • Exchange
    KQ
  • Isin
    KR7048410005
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Biotechnology
  • CEO
    Jong-Won Choi
  • Headquarter
    Seoul
  • Web site
    https://www.hyundaibioscience.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top